Laboratory‐Based Surveillance of Paratyphoid Fever in the United States: Travel and Antimicrobial Resistance
Author(s) -
Sundeep Gupta,
Felicita Medalla,
Michael Omondi,
Jean M. Whichard,
Patricia I. Fields,
Peter GernerSmidt,
Nehal Patel,
Kara Cooper,
Tom Chiller,
Eric D. Mintz
Publication year - 2008
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/587894
Subject(s) - nalidixic acid , paratyphoid fever , medicine , salmonella , ciprofloxacin , serotype , incidence (geometry) , microbiology and biotechnology , virology , typhoid fever , antibiotics , biology , bacteria , genetics , physics , optics
The incidence of paratyphoid fever, including paratyphoid fever caused by antimicrobial-resistant strains, is increasing globally. However, the epidemiologic and laboratory characteristics of paratyphoid fever in the United States have never been studied.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom